LIQUIDIA CORPORATION Public Float
LIQUIDIA CORPORATION (LQDA) had Public Float of $847.01 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $847.01M.
- 2024-06-30: Entity Public Float $685.66M.
- 2023-06-30: Entity Public Float $368.58M.
- 2022-06-30: Entity Public Float $205.44M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $847.01M 10-K · filed 2026-03-05 |
| 2024-06-30 | $685.66M 10-K · filed 2025-03-19 |
| 2023-06-30 | $368.58M 10-K · filed 2024-03-13 |
| 2022-06-30 | $205.44M 10-K · filed 2023-03-20 |
| 2021-06-30 | $61.67M 10-K · filed 2022-03-17 |
| 2020-06-30 | $212.93M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |